Axsome Therapeutics (AXSM) Operating Margin Growth (3y) (2025 - 2026)
Axsome Therapeutics (AXSM) Operating Margin Growth (3y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - | - |
| 4 | BeOne Medicines | 471.51 Bn | 466.72 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.70 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.88 Bn | 50.69 Bn | 1.41 Bn | -623.00 |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 6,993.00 |
| 10 | Axsome Therapeutics | 12.25 Bn | 11.94 Bn | 176.48 Mn | -2,640.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,640.00 |
| Dec 31, 2025 | 23,210.00 |
| Sep 30, 2025 | 22,480.00 |
| Jun 30, 2025 | 41,976.00 |